The available report is connected directly to the listing.
Form / material film360° studio loop
Hyperreal material study08.1 sec / seamless
FORM / LOT RECORD
Linked before ordering.
- 01
- Identity
- 02
- Method
- 03
- Lot match
Weight Management
Available for research
Lot-documented reference material
Tesamorelin 10 mg
A synthetic peptide reference material with lot-specific identity and purity documentation.
99.2%
Reported purityCurrent lot DPS-4250856 · UPLC + mass spectrometry
View lot report →
$110
CoA available
One-time research orderNo subscription
Free U.S. shipping · Freeze-dried · CoA available
Lab-reported identityUPLC & mass spectrometry
Lot matchedCoA available
Freeze-driedReference material
Research onlyQualified buyers
01Material details
Review the identity, current reported result, methods, storage note, and document status in the material table below.
02Independent record
Open the independent report above to verify the values published on this page before placing a research order.
03Research-use requirements
For laboratory research only. Never for use in people or animals. Obtain and review the supplier-issued SDS before handling or storage.
04Potential human benefits
- Visceral-fat reductionPharmaceutical tesamorelin has reduced visceral abdominal fat in adults with HIV lipodystrophy, targeting the metabolically active fat surrounding internal organs rather than acting as a general weight-loss drug.
- Liver fat + triglyceridesClinical research has reported reductions in liver fat and triglycerides in selected populations, suggesting a potential role for GH-axis signaling in ectopic-fat and lipid metabolism.
- Brain-health potentialExploratory human studies have examined memory and executive function because GHRH signaling may influence sleep, metabolism, and neurotrophic pathways. The cognitive evidence remains preliminary.
The Form standard
Built to be examined,
not assumed.
Every listing keeps the material, current record, and research boundary in one clear review path.
Review the stated analytical methods before ordering.
Presented as a laboratory reference material.
Research only. Never for use in people or animals.
Potential human relevance
Targeted visceral-fat biology
with human clinical proof.
Tesamorelin stimulates the body’s own growth-hormone pulses and is FDA-approved in a pharmaceutical form to reduce excess abdominal fat in adults with HIV lipodystrophy. Human trials have also explored liver fat, triglycerides, and cognition, making it one of the better-characterized peptides in this catalog.
Visceral-fat reduction
Pharmaceutical tesamorelin has reduced visceral abdominal fat in adults with HIV lipodystrophy, targeting the metabolically active fat surrounding internal organs rather than acting as a general weight-loss drug.
Liver fat + triglycerides
Clinical research has reported reductions in liver fat and triglycerides in selected populations, suggesting a potential role for GH-axis signaling in ectopic-fat and lipid metabolism.
Brain-health potential
Exploratory human studies have examined memory and executive function because GHRH signaling may influence sleep, metabolism, and neurotrophic pathways. The cognitive evidence remains preliminary.
How the potential connects to the biology
Why it may matter
Growth-hormone-releasing-hormone receptor signaling and the downstream GH/IGF axis.
What studies track
Hormone pulse profiles, IGF-1 measurements, glucose-clamp endpoints, and metabolic markers in defined studies.
How strong is the evidence?
Randomized human trials and an FDA-approved indication for a specific pharmaceutical tesamorelin formulation; not approved for general weight loss.
What remains unknown: The strongest evidence is limited to pharmaceutical tesamorelin in defined clinical populations. Long-term cardiovascular safety is not established, and it is not indicated for general weight management.
Material details
The essentials.
The current lot report lists the chemical form, identity values, purity result, and test methods.
| Amount | 10 mg per vial |
|---|---|
| CAS number | 901758-09-6 |
| Molecular formula | C223H370N72O69S (lot form reported on CoA) |
| Molecular weight | Approximately 5196 g/mol |
| Lot result | 99.2% purity; white lyophilized powder |
| Tested by | Horizon Analytical; lot DPS-4250856; UPLC and mass spectrometry |
| Storage | Not stated on the current lot CoA. Obtain and follow the supplier-issued SDS before handling or storage. |
| Lab records | Current lot CoA (PDF) · Request supplier-issued SDS |
SDS status: not currently posted. Request and review the supplier SDS before handling or storage; this page and CoA do not replace it.
Made for research
For in-vitro lab research, method development, and identity testing by qualified research customers.
Proof by lot
The available CoA is tied to this material and lot. Open it above or visit the CoA library.
Clear limits
For laboratory research only. Never for use in people or animals.
Before you order
By ordering, you confirm qualified research-only use.
